{"transactions":[{"id":3107795,"issuer":{"id":67174,"kind":"organization","name":"Generation Bio Co.","symbol":"GBIO"},"owners":[{"id":148402,"kind":"organization","name":"Zone Healthcare Holdings, LLC","position":1,"cik":"0001814952","reported_name":"Zone Healthcare Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":2,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Manager of ZHH LLC"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":3,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Farallon General Partner"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":4,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":5,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76246,"kind":"person","name":"FRIED RICHARD B","position":6,"cik":"0001245637","reported_name":"FRIED RICHARD B","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76249,"kind":"person","name":"Kim David T","position":7,"cik":"0001595643","reported_name":"Kim David T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76250,"kind":"person","name":"Linn Michael G","position":8,"cik":"0001495856","reported_name":"Linn Michael G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76260,"kind":"person","name":"PATEL RAJIV A","position":9,"cik":"0001275110","reported_name":"PATEL RAJIV A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76261,"kind":"person","name":"Roberts Thomas G. Jr.","position":10,"cik":"0001453042","reported_name":"Roberts Thomas G. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}}],"security":"Series C Preferred Stock","published_at":"2020-06-17T21:00:06.000Z","date":"2020-06-16","kind":"exercise","acquired":false,"shares":2682691,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 16, 2020, Generation Bio Co. (the \"Issuer\") announced the completion of its initial public offering (the \"IPO\").  Upon the IPO, the outstanding Series C Preferred Stock of the Issuer converted automatically into shares of Common Stock of the Issuer on a 1.7663-for-one basis without payment of further consideration.  The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 16, 2020, Generation Bio Co. (the \"Issuer\") announced the completion of its initial public offering (the \"IPO\").  Upon the IPO, the outstanding Series C Preferred Stock of the Issuer converted automatically into shares of Common Stock of the Issuer on a 1.7663-for-one basis without payment of further consideration.  The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 16, 2020, Generation Bio Co. (the \"Issuer\") announced the completion of its initial public offering (the \"IPO\").  Upon the IPO, the outstanding Series C Preferred Stock of the Issuer converted automatically into shares of Common Stock of the Issuer on a 1.7663-for-one basis without payment of further consideration.  The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 16, 2020, Generation Bio Co. (the \"Issuer\") announced the completion of its initial public offering (the \"IPO\").  Upon the IPO, the outstanding Series C Preferred Stock of the Issuer converted automatically into shares of Common Stock of the Issuer on a 1.7663-for-one basis without payment of further consideration.  The Series C Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The entities and individuals identified in the footnotes to this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such a group."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing one or more additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (each, a \"Parallel Form 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in any Parallel Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The amount of securities shown in this row is owned directly by Zone Healthcare Holdings, LLC (\"ZHH LLC\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F10","text":"Due to the dilutive effect of the IPO, as of the completion of the IPO no reporting person on or otherwise referred to in this Form 4 or any Parallel Form 4 has beneficial ownership of more than 10% of the outstanding class of Common Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1518819},"source":{"system":"sec-edgar","filing":"0001214659-20-005727","document":"marketforms-49046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/909661/000121465920005727/marketforms-49046.xml","form_type":"4"}},{"id":3107794,"issuer":{"id":67174,"kind":"organization","name":"Generation Bio Co.","symbol":"GBIO"},"owners":[{"id":148402,"kind":"organization","name":"Zone Healthcare Holdings, LLC","position":1,"cik":"0001814952","reported_name":"Zone Healthcare Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":2,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Manager of ZHH LLC"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":3,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Farallon General Partner"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":4,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":5,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76246,"kind":"person","name":"FRIED RICHARD B","position":6,"cik":"0001245637","reported_name":"FRIED RICHARD B","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76249,"kind":"person","name":"Kim David T","position":7,"cik":"0001595643","reported_name":"Kim David T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76250,"kind":"person","name":"Linn Michael G","position":8,"cik":"0001495856","reported_name":"Linn Michael G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76260,"kind":"person","name":"PATEL RAJIV A","position":9,"cik":"0001275110","reported_name":"PATEL RAJIV A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76261,"kind":"person","name":"Roberts Thomas G. Jr.","position":10,"cik":"0001453042","reported_name":"Roberts Thomas G. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}}],"security":"Common Stock","published_at":"2020-06-17T21:00:06.000Z","date":"2020-06-16","kind":"purchase","acquired":true,"shares":400000,"price":19,"value":7600000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The entities and individuals identified in the footnotes to this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such a group."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing one or more additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (each, a \"Parallel Form 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in any Parallel Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The amount of securities shown in this row is owned directly by Zone Healthcare Holdings, LLC (\"ZHH LLC\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F10","text":"Due to the dilutive effect of the IPO, as of the completion of the IPO no reporting person on or otherwise referred to in this Form 4 or any Parallel Form 4 has beneficial ownership of more than 10% of the outstanding class of Common Stock."}],"balance_after":1918819,"source":{"system":"sec-edgar","filing":"0001214659-20-005727","document":"marketforms-49046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/909661/000121465920005727/marketforms-49046.xml","form_type":"4"}},{"id":3107793,"issuer":{"id":67174,"kind":"organization","name":"Generation Bio Co.","symbol":"GBIO"},"owners":[{"id":148402,"kind":"organization","name":"Zone Healthcare Holdings, LLC","position":1,"cik":"0001814952","reported_name":"Zone Healthcare Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":2,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Manager of ZHH LLC"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":3,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Farallon General Partner"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":4,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":5,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76246,"kind":"person","name":"FRIED RICHARD B","position":6,"cik":"0001245637","reported_name":"FRIED RICHARD B","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76249,"kind":"person","name":"Kim David T","position":7,"cik":"0001595643","reported_name":"Kim David T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76250,"kind":"person","name":"Linn Michael G","position":8,"cik":"0001495856","reported_name":"Linn Michael G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76260,"kind":"person","name":"PATEL RAJIV A","position":9,"cik":"0001275110","reported_name":"PATEL RAJIV A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}},{"id":76261,"kind":"person","name":"Roberts Thomas G. Jr.","position":10,"cik":"0001453042","reported_name":"Roberts Thomas G. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Managing Member"}}],"security":"Common Stock","published_at":"2020-06-17T21:00:06.000Z","date":"2020-06-16","kind":"exercise","acquired":true,"shares":1518819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 16, 2020, Generation Bio Co. (the \"Issuer\") announced the completion of its initial public offering (the \"IPO\").  Upon the IPO, the outstanding Series C Preferred Stock of the Issuer converted automatically into shares of Common Stock of the Issuer on a 1.7663-for-one basis without payment of further consideration.  The Series C Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The entities and individuals identified in the footnotes to this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such a group."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing one or more additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (each, a \"Parallel Form 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in any Parallel Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The amount of securities shown in this row is owned directly by Zone Healthcare Holdings, LLC (\"ZHH LLC\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F10","text":"Due to the dilutive effect of the IPO, as of the completion of the IPO no reporting person on or otherwise referred to in this Form 4 or any Parallel Form 4 has beneficial ownership of more than 10% of the outstanding class of Common Stock."}],"balance_after":1518819,"source":{"system":"sec-edgar","filing":"0001214659-20-005727","document":"marketforms-49046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/909661/000121465920005727/marketforms-49046.xml","form_type":"4"}},{"id":4246326,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":2648696,"price":6.72,"value":17799237.12,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The amount of securities shown in this row is owned directly by the Farallon SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Each of Philip D. Dreyfuss, Michael B. Fisch, Richard B. Fried, David T. Kim, Monica R. Landry, Michael G. Linn, Ravi K. Paidipaty, Rajiv A. Patel, Thomas G. Roberts, Jr., William Seybold, John R. Warren and Mark C. Wehrly (collectively, the \"Managing Members\") and Andrew J. M. Spokes (the \"Senior Managing Member\"), as Managing Members or the Senior Managing Member, as the case may be, of both the Farallon General Partner and the Management Company, and as a manager or senior manager, as the case may be, of both the FCAAI GP and the FSSP VI GP, in each case with the power to exercise investment discretion, may be deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. Each of the Managing Members and the Senior Managing Member disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except to the extent of his or her pecuniary interest, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"As a director of the Issuer, Patel is filing a separate Form 4 on the date hereof."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246325,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":2067651,"price":6.72,"value":13894614.72,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"As the general partner of each of (a) the sole member of FCIP XR, (b) the sole member of FCP XR, (c) FCIP III, (d) the sole member of FCOI II SS and (e) FCIP II, Farallon Partners, L.L.C. (the \"Farallon General Partner\") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCIP XR as a Farallon Akubra Fund, FCP XR and FCIP III as Farallon Bushranger Funds, and FCOI II SS and FCIP II as Farallon Ute Funds. The Farallon General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, the Farallon SPVs."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246324,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":209577,"price":6.72,"value":1408357.44,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The amount of securities shown in this row is owned directly by Ute Holdings, LLC (\"Ute\" and, together with Akubra and Bushranger, the \"Farallon SPVs\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The members of Ute are FCOI II SS 2014, Ltd. (\"FCOI II SS\"), Farallon Capital Institutional Partners II, L.P. (\"FCIP II\"), and Farallon Special Situation Partners VI, L.P. (\"FSSP VI\") (collectively, the \"Farallon Ute Funds\"). As the general partner of FSSP VI, Farallon Partners GP VI, L.L.C. (the \"FSSP VI GP\") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FSSP VI as a Farallon Ute Fund. The FSSP VI GP disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Ute."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246323,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":249462,"price":6.72,"value":1676384.64,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The amount of securities shown in this row is owned directly by Bushranger Funding, LLC (\"Bushranger\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The members of Bushranger are FCP XR 2014, L.L.C. (\"FCP XR\"), Farallon Capital Institutional Partners III, L.P. (\"FCIP III\"), and Farallon Capital AA Investors, L.P. (\"FCAAI\") (collectively, the \"Farallon Bushranger Funds\"). As the general partner of FCAAI, Farallon AA GP, L.L.C. (the \"FCAAI GP\") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCAAI as a Farallon Bushranger Fund. The FCAAI GP disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Bushranger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246322,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":122006,"price":6.72,"value":819880.32,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The amount of securities shown in this row is owned directly by Akubra Investors, LLC (\"Akubra\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The members of Akubra are FCIP XR 2014, L.L.C. (\"FCIP XR\") and Noonday Special Situation Partners, L.P. (\"NSSP\") (each, a \"Farallon Akubra Fund\"). As the general partner of NSSP, NGP, L.L.C. (the \"NSSP General Partner\") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by NSSP as a Farallon Akubra Fund. The NSSP General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"'34 Act\"), or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"As the manager of the NSSP General Partner, Farallon Capital Management, L.L.C. (the \"Management Company\") may be deemed to be a beneficial owner of the Issuer's securities held by NSSP as a Farallon Akubra Fund. The Management Company disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246321,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":915583,"price":6.72,"value":6152717.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The amount of securities shown in this row is owned directly by Ute Holdings, LLC (\"Ute\" and, together with Akubra and Bushranger, the \"Farallon SPVs\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246320,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":899268,"price":6.72,"value":6043080.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The amount of securities shown in this row is owned directly by Bushranger Funding, LLC (\"Bushranger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}},{"id":4246319,"issuer":{"id":174046,"kind":"organization","name":"Nexvet Biopharma plc","symbol":"NVET"},"owners":[{"id":103448,"kind":"organization","name":"FARALLON CAPITAL MANAGEMENT, L.L.C.","position":1,"cik":"0000909661","reported_name":"FARALLON CAPITAL MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76242,"kind":"organization","name":"FARALLON PARTNERS L L C/CA","position":2,"cik":"0001040153","reported_name":"FARALLON PARTNERS L L C/CA","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174074,"kind":"organization","name":"Akubra Investors, LLC","position":3,"cik":"0001632596","reported_name":"Akubra Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174075,"kind":"organization","name":"Bushranger Funding, LLC","position":4,"cik":"0001632625","reported_name":"Bushranger Funding, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174076,"kind":"organization","name":"Ute Holdings, LLC","position":5,"cik":"0001632627","reported_name":"Ute Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174077,"kind":"organization","name":"Farallon AA G.P., L.L.C.","position":6,"cik":"0001632734","reported_name":"Farallon AA G.P., L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174078,"kind":"organization","name":"Farallon Partners GP VI, L.L.C.","position":7,"cik":"0001632735","reported_name":"Farallon Partners GP VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":174079,"kind":"organization","name":"NGP, L.L.C.","position":8,"cik":"0001632660","reported_name":"NGP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":76244,"kind":"person","name":"Dreyfuss Philip D","position":9,"cik":"0001693981","reported_name":"Dreyfuss Philip D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}},{"id":121554,"kind":"person","name":"Fisch Michael B.","position":10,"cik":"0001611816","reported_name":"Fisch Michael B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Member of Group Owning 10%"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:54:05.000Z","date":"2017-07-31","kind":"other","acquired":false,"shares":833845,"price":6.72,"value":5603438.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. (\"Zoetis\") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis (\"Bidco\"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the \"Acquisition\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the \"Parallel Forms 4\"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The amount of securities shown in this row is owned directly by Akubra Investors, LLC (\"Akubra\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001182489-17-000447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/909661/000118248917000447/edgar.xml","form_type":"4"}}]}